Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.54503428 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.54503428 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.20259288 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.20259288 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.72155466 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.46375237 |
7 | indole-containing compound catabolic process (GO:0042436) | 6.00189188 |
8 | indolalkylamine catabolic process (GO:0046218) | 6.00189188 |
9 | tryptophan catabolic process (GO:0006569) | 6.00189188 |
10 | kynurenine metabolic process (GO:0070189) | 5.92752843 |
11 | intestinal cholesterol absorption (GO:0030299) | 5.91957862 |
12 | negative regulation of fibrinolysis (GO:0051918) | 5.88693367 |
13 | bile acid biosynthetic process (GO:0006699) | 5.86163211 |
14 | glyoxylate metabolic process (GO:0046487) | 5.78346159 |
15 | urea cycle (GO:0000050) | 5.72523984 |
16 | urea metabolic process (GO:0019627) | 5.72523984 |
17 | regulation of plasminogen activation (GO:0010755) | 5.72224905 |
18 | regulation of apoptotic cell clearance (GO:2000425) | 5.72180755 |
19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.71978199 |
20 | tryptophan metabolic process (GO:0006568) | 5.66723532 |
21 | regulation of fibrinolysis (GO:0051917) | 5.64973181 |
22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.55852666 |
23 | protein carboxylation (GO:0018214) | 5.45758259 |
24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45758259 |
25 | regulation of protein activation cascade (GO:2000257) | 5.44924578 |
26 | cysteine metabolic process (GO:0006534) | 5.40058404 |
27 | complement activation, alternative pathway (GO:0006957) | 5.38003352 |
28 | sulfur amino acid catabolic process (GO:0000098) | 5.35755779 |
29 | nitrogen cycle metabolic process (GO:0071941) | 5.25540485 |
30 | serine family amino acid catabolic process (GO:0009071) | 5.10486455 |
31 | reverse cholesterol transport (GO:0043691) | 5.07427614 |
32 | regulation of complement activation (GO:0030449) | 5.06141859 |
33 | bile acid metabolic process (GO:0008206) | 5.04131686 |
34 | regulation of cholesterol esterification (GO:0010872) | 4.99797009 |
35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.95059078 |
36 | protein-lipid complex remodeling (GO:0034368) | 4.95059078 |
37 | macromolecular complex remodeling (GO:0034367) | 4.95059078 |
38 | aromatic amino acid family metabolic process (GO:0009072) | 4.88060593 |
39 | regulation of triglyceride catabolic process (GO:0010896) | 4.86238720 |
40 | homocysteine metabolic process (GO:0050667) | 4.83646800 |
41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.80316558 |
42 | tyrosine metabolic process (GO:0006570) | 4.79831131 |
43 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.69617032 |
44 | phospholipid efflux (GO:0033700) | 4.69397561 |
45 | triglyceride homeostasis (GO:0070328) | 4.66232808 |
46 | acylglycerol homeostasis (GO:0055090) | 4.66232808 |
47 | negative regulation of blood coagulation (GO:0030195) | 4.65910389 |
48 | negative regulation of hemostasis (GO:1900047) | 4.65910389 |
49 | amino-acid betaine metabolic process (GO:0006577) | 4.61607253 |
50 | alpha-amino acid catabolic process (GO:1901606) | 4.61204420 |
51 | regulation of humoral immune response (GO:0002920) | 4.60918128 |
52 | positive regulation of blood coagulation (GO:0030194) | 4.58055458 |
53 | positive regulation of hemostasis (GO:1900048) | 4.58055458 |
54 | negative regulation of sterol transport (GO:0032372) | 4.57485934 |
55 | negative regulation of cholesterol transport (GO:0032375) | 4.57485934 |
56 | plasma lipoprotein particle clearance (GO:0034381) | 4.56416140 |
57 | lysine metabolic process (GO:0006553) | 4.54500813 |
58 | lysine catabolic process (GO:0006554) | 4.54500813 |
59 | cellular ketone body metabolic process (GO:0046950) | 4.46404601 |
60 | acute-phase response (GO:0006953) | 4.45818525 |
61 | glycine metabolic process (GO:0006544) | 4.42528703 |
62 | cholesterol efflux (GO:0033344) | 4.38255735 |
63 | bile acid and bile salt transport (GO:0015721) | 4.37143343 |
64 | imidazole-containing compound metabolic process (GO:0052803) | 4.33068241 |
65 | negative regulation of coagulation (GO:0050819) | 4.28392694 |
66 | glutamate metabolic process (GO:0006536) | 4.26178416 |
67 | indolalkylamine metabolic process (GO:0006586) | 4.25820503 |
68 | cellular amino acid catabolic process (GO:0009063) | 4.24748928 |
69 | coenzyme catabolic process (GO:0009109) | 4.22531009 |
70 | plasma lipoprotein particle assembly (GO:0034377) | 4.21141719 |
71 | serine family amino acid metabolic process (GO:0009069) | 4.18008634 |
72 | low-density lipoprotein particle remodeling (GO:0034374) | 4.17668199 |
73 | positive regulation of coagulation (GO:0050820) | 4.17487022 |
74 | negative regulation of complement activation (GO:0045916) | 4.17072018 |
75 | cellular glucuronidation (GO:0052695) | 4.16720415 |
76 | amine catabolic process (GO:0009310) | 4.15699583 |
77 | cellular biogenic amine catabolic process (GO:0042402) | 4.15699583 |
78 | fibrinolysis (GO:0042730) | 4.15082770 |
79 | negative regulation of wound healing (GO:0061045) | 4.10937807 |
80 | epoxygenase P450 pathway (GO:0019373) | 4.08412635 |
81 | serine family amino acid biosynthetic process (GO:0009070) | 4.06923485 |
82 | cellular modified amino acid catabolic process (GO:0042219) | 4.06726649 |
83 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05910082 |
84 | lipoprotein metabolic process (GO:0042157) | 4.04500833 |
85 | benzene-containing compound metabolic process (GO:0042537) | 4.03529632 |
86 | blood coagulation, intrinsic pathway (GO:0007597) | 4.03134260 |
87 | ethanol oxidation (GO:0006069) | 4.02718718 |
88 | arginine metabolic process (GO:0006525) | 4.01609069 |
89 | aldehyde catabolic process (GO:0046185) | 3.99078849 |
90 | exogenous drug catabolic process (GO:0042738) | 3.93852833 |
91 | positive regulation of extracellular matrix organization (GO:1903055) | 3.90980176 |
92 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.88591889 |
93 | phospholipid homeostasis (GO:0055091) | 3.88008781 |
94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.87538993 |
95 | ketone body metabolic process (GO:1902224) | 3.86274199 |
96 | drug catabolic process (GO:0042737) | 3.86099846 |
97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.85981263 |
98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.85981263 |
99 | cholesterol transport (GO:0030301) | 3.83104754 |
100 | sterol transport (GO:0015918) | 3.83104754 |
101 | positive regulation of lipid catabolic process (GO:0050996) | 3.81720676 |
102 | intestinal absorption (GO:0050892) | 3.81231561 |
103 | cholesterol homeostasis (GO:0042632) | 3.80930358 |
104 | plasma lipoprotein particle organization (GO:0071827) | 3.79400636 |
105 | protein activation cascade (GO:0072376) | 3.78444875 |
106 | protein-lipid complex assembly (GO:0065005) | 3.77585284 |
107 | cofactor catabolic process (GO:0051187) | 3.76123951 |
108 | negative regulation of lipase activity (GO:0060192) | 3.75675413 |
109 | sterol homeostasis (GO:0055092) | 3.74556769 |
110 | complement activation, classical pathway (GO:0006958) | 3.74194071 |
111 | complement activation (GO:0006956) | 3.73363407 |
112 | organic acid catabolic process (GO:0016054) | 3.70913774 |
113 | carboxylic acid catabolic process (GO:0046395) | 3.70913774 |
114 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.69969264 |
115 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.69942303 |
116 | glucuronate metabolic process (GO:0019585) | 3.69200571 |
117 | uronic acid metabolic process (GO:0006063) | 3.69200571 |
118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67430572 |
119 | proline metabolic process (GO:0006560) | 3.65175500 |
120 | negative regulation of protein activation cascade (GO:2000258) | 3.63849452 |
121 | short-chain fatty acid metabolic process (GO:0046459) | 3.61531187 |
122 | low-density lipoprotein particle clearance (GO:0034383) | 3.59188152 |
123 | regulation of cholesterol homeostasis (GO:2000188) | 3.58800289 |
124 | acetyl-CoA metabolic process (GO:0006084) | 3.56990656 |
125 | protein-lipid complex subunit organization (GO:0071825) | 3.56802776 |
126 | cytolysis (GO:0019835) | 3.55847781 |
127 | positive regulation of steroid metabolic process (GO:0045940) | 3.55713167 |
128 | diacylglycerol metabolic process (GO:0046339) | 3.52064007 |
129 | ethanol metabolic process (GO:0006067) | 3.51300258 |
130 | omega-hydroxylase P450 pathway (GO:0097267) | 3.40002032 |
131 | acute inflammatory response (GO:0002526) | 3.31635101 |
132 | peptidyl-glutamic acid modification (GO:0018200) | 3.28022076 |
133 | negative regulation of lipid transport (GO:0032369) | 3.23955850 |
134 | lipid homeostasis (GO:0055088) | 3.22809216 |
135 | negative regulation of humoral immune response (GO:0002921) | 3.21700201 |
136 | regulation of cholesterol metabolic process (GO:0090181) | 3.21015029 |
137 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.19101269 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.40208202 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19572967 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.01747460 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.55474325 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28761345 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.18392382 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80750626 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.04905952 |
9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.00497210 |
10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.35534596 |
11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09668007 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01722289 |
13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0209191 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94501324 |
15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.94487949 |
16 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.68437895 |
17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63788969 |
18 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.60737681 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60314127 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57866689 |
21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.56934596 |
22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56178646 |
23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.44793949 |
24 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42897592 |
25 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41723036 |
26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34306426 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31784612 |
28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22511668 |
29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19689046 |
30 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19293234 |
31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17218494 |
32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.15670300 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98191294 |
34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97300000 |
35 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96342697 |
36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93565803 |
37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92797906 |
38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91126746 |
39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90571821 |
40 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.89200025 |
41 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87861814 |
42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87409515 |
43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83584756 |
44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83378835 |
45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83195103 |
46 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83116262 |
47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82724701 |
48 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80787281 |
49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79941682 |
50 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78729628 |
51 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.78238093 |
52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.76501720 |
53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76396838 |
54 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.75344932 |
55 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75026550 |
56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.74718737 |
57 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74037608 |
58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73247185 |
59 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72941039 |
60 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72603908 |
61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.72570137 |
62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72370602 |
63 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.72070782 |
64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71182326 |
65 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.70268373 |
66 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69234180 |
67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.67073818 |
68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66450783 |
69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.66101264 |
70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65521509 |
71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65521509 |
72 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.64544556 |
73 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.62177812 |
74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61884269 |
75 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.61875226 |
76 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.61586801 |
77 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.61479683 |
78 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61236233 |
79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.60470198 |
80 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59955545 |
81 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59494420 |
82 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59005256 |
83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58925152 |
84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57442906 |
85 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.57122383 |
86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.55364032 |
87 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55232609 |
88 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.55085481 |
89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.54830680 |
90 | TP53_16413492_ChIP-PET_HCT116_Human | 0.54769816 |
91 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.54526796 |
92 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54449057 |
93 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.54365218 |
94 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.54322247 |
95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52621991 |
96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52144455 |
97 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51986914 |
98 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51380066 |
99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51294349 |
100 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.50935769 |
101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.49170730 |
102 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.49127405 |
103 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.49061214 |
104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48755500 |
105 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48173199 |
106 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.48123566 |
107 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.47540180 |
108 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47227686 |
109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46957053 |
110 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46702739 |
111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46543723 |
112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46372432 |
113 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46352026 |
114 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45384464 |
115 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.45095834 |
116 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.44454653 |
117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.43409739 |
118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43106472 |
119 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42107852 |
120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41966252 |
121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.41507263 |
122 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41379403 |
123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39878933 |
124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39531543 |
125 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.39194992 |
126 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38803124 |
127 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38765804 |
128 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38164847 |
129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36981843 |
130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.36937598 |
131 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36927382 |
132 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34505350 |
133 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34460475 |
134 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34435851 |
135 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34102869 |
136 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33892785 |
137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33543264 |
138 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.32861835 |
139 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.32422608 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.22510838 |
2 | MP0005360_urolithiasis | 7.52884081 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.43554166 |
4 | MP0005365_abnormal_bile_salt | 6.17477662 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04611225 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.21847247 |
7 | MP0003122_maternal_imprinting | 3.95635495 |
8 | MP0003252_abnormal_bile_duct | 3.89453773 |
9 | MP0010329_abnormal_lipoprotein_level | 3.63903868 |
10 | MP0009840_abnormal_foam_cell | 3.31359349 |
11 | MP0005083_abnormal_biliary_tract | 3.23448651 |
12 | MP0003195_calcinosis | 2.85246135 |
13 | MP0005332_abnormal_amino_acid | 2.74026740 |
14 | MP0001666_abnormal_nutrient_absorption | 2.62837923 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.41407668 |
16 | MP0000566_synostosis | 2.23561289 |
17 | MP0000609_abnormal_liver_physiology | 2.18681248 |
18 | MP0004019_abnormal_vitamin_homeostasis | 2.14114425 |
19 | MP0002118_abnormal_lipid_homeostasis | 2.09809453 |
20 | MP0003123_paternal_imprinting | 2.01783073 |
21 | MP0002138_abnormal_hepatobiliary_system | 1.98198493 |
22 | MP0003868_abnormal_feces_composition | 1.94771416 |
23 | MP0001915_intracranial_hemorrhage | 1.85284006 |
24 | MP0005319_abnormal_enzyme/_coenzyme | 1.81192656 |
25 | MP0002089_abnormal_postnatal_growth/wei | 1.79183408 |
26 | MP0001764_abnormal_homeostasis | 1.66963781 |
27 | MP0009697_abnormal_copulation | 1.64272040 |
28 | MP0005058_abnormal_lysosome_morphology | 1.57094483 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56442782 |
30 | MP0003656_abnormal_erythrocyte_physiolo | 1.47547529 |
31 | MP0003011_delayed_dark_adaptation | 1.46897759 |
32 | MP0003172_abnormal_lysosome_physiology | 1.44594686 |
33 | MP0005451_abnormal_body_composition | 1.39158679 |
34 | MP0003186_abnormal_redox_activity | 1.26391574 |
35 | MP0009643_abnormal_urine_homeostasis | 1.22561203 |
36 | MP0003705_abnormal_hypodermis_morpholog | 1.22298886 |
37 | MP0000598_abnormal_liver_morphology | 1.20429876 |
38 | MP0006054_spinal_hemorrhage | 1.19239677 |
39 | MP0003121_genomic_imprinting | 1.13226094 |
40 | MP0000604_amyloidosis | 1.13038109 |
41 | MP0005647_abnormal_sex_gland | 1.10783276 |
42 | MP0002254_reproductive_system_inflammat | 1.09474976 |
43 | MP0004272_abnormal_basement_membrane | 1.08777626 |
44 | MP0005409_darkened_coat_color | 1.06956329 |
45 | MP0009764_decreased_sensitivity_to | 1.04939101 |
46 | MP0009763_increased_sensitivity_to | 1.04489805 |
47 | MP0010368_abnormal_lymphatic_system | 1.01970738 |
48 | MP0009780_abnormal_chondrocyte_physiolo | 0.96421817 |
49 | MP0005636_abnormal_mineral_homeostasis | 0.96080759 |
50 | MP0005167_abnormal_blood-brain_barrier | 0.90352770 |
51 | MP0005257_abnormal_intraocular_pressure | 0.88923183 |
52 | MP0008469_abnormal_protein_level | 0.88609112 |
53 | MP0005408_hypopigmentation | 0.88429997 |
54 | MP0009642_abnormal_blood_homeostasis | 0.87357987 |
55 | MP0005084_abnormal_gallbladder_morpholo | 0.82103727 |
56 | MP0003950_abnormal_plasma_membrane | 0.82007372 |
57 | MP0005376_homeostasis/metabolism_phenot | 0.80606427 |
58 | MP0006036_abnormal_mitochondrial_physio | 0.79873243 |
59 | MP0009765_abnormal_xenobiotic_induced | 0.79383223 |
60 | MP0002078_abnormal_glucose_homeostasis | 0.77754512 |
61 | MP0005220_abnormal_exocrine_pancreas | 0.77304924 |
62 | MP0003567_abnormal_fetal_cardiomyocyte | 0.75821892 |
63 | MP0005670_abnormal_white_adipose | 0.72674618 |
64 | MP0002933_joint_inflammation | 0.72542378 |
65 | MP0001661_extended_life_span | 0.71601731 |
66 | MP0002971_abnormal_brown_adipose | 0.70795510 |
67 | MP0009053_abnormal_anal_canal | 0.70171238 |
68 | MP0002876_abnormal_thyroid_physiology | 0.69921795 |
69 | MP0004130_abnormal_muscle_cell | 0.69103350 |
70 | MP0003690_abnormal_glial_cell | 0.68687594 |
71 | MP0005334_abnormal_fat_pad | 0.67674953 |
72 | MP0003183_abnormal_peptide_metabolism | 0.67161080 |
73 | MP0003943_abnormal_hepatobiliary_system | 0.66507588 |
74 | MP0000639_abnormal_adrenal_gland | 0.64318552 |
75 | MP0005535_abnormal_body_temperature | 0.64186684 |
76 | MP0003329_amyloid_beta_deposits | 0.62420195 |
77 | MP0005266_abnormal_metabolism | 0.61964432 |
78 | MP0003879_abnormal_hair_cell | 0.61832512 |
79 | MP0000003_abnormal_adipose_tissue | 0.60994489 |
80 | MP0003632_abnormal_nervous_system | 0.60892900 |
81 | MP0005464_abnormal_platelet_physiology | 0.60767284 |
82 | MP0002282_abnormal_trachea_morphology | 0.60732288 |
83 | MP0003566_abnormal_cell_adhesion | 0.60396484 |
84 | MP0005076_abnormal_cell_differentiation | 0.59968673 |
85 | MP0004264_abnormal_extraembryonic_tissu | 0.59714202 |
86 | MP0001756_abnormal_urination | 0.59270270 |
87 | MP0003315_abnormal_perineum_morphology | 0.59126732 |
88 | MP0001270_distended_abdomen | 0.57617506 |
89 | MP0000920_abnormal_myelination | 0.57568437 |
90 | MP0003115_abnormal_respiratory_system | 0.57533181 |
91 | MP0003878_abnormal_ear_physiology | 0.56910401 |
92 | MP0005377_hearing/vestibular/ear_phenot | 0.56910401 |
93 | MP0005448_abnormal_energy_balance | 0.55957991 |
94 | MP0001324_abnormal_eye_pigmentation | 0.54701488 |
95 | MP0006035_abnormal_mitochondrial_morpho | 0.54619476 |
96 | MP0002909_abnormal_adrenal_gland | 0.54317707 |
97 | MP0003941_abnormal_skin_development | 0.53909875 |
98 | MP0005410_abnormal_fertilization | 0.53084862 |
99 | MP0002938_white_spotting | 0.52479130 |
100 | MP0005023_abnormal_wound_healing | 0.52265302 |
101 | MP0005395_other_phenotype | 0.50073603 |
102 | MP0003890_abnormal_embryonic-extraembry | 0.45929102 |
103 | MP0002928_abnormal_bile_duct | 0.45729760 |
104 | MP0003718_maternal_effect | 0.45431825 |
105 | MP0002136_abnormal_kidney_physiology | 0.44982933 |
106 | MP0003638_abnormal_response/metabolism_ | 0.44874615 |
107 | MP0008873_increased_physiological_sensi | 0.44361381 |
108 | MP0002822_catalepsy | 0.43049506 |
109 | MP0008874_decreased_physiological_sensi | 0.42994616 |
110 | MP0003942_abnormal_urinary_system | 0.42565460 |
111 | MP0003436_decreased_susceptibility_to | 0.42491662 |
112 | MP0000858_altered_metastatic_potential | 0.42459150 |
113 | MP0003075_altered_response_to | 0.41366322 |
114 | MP0003724_increased_susceptibility_to | 0.40977835 |
115 | MP0005379_endocrine/exocrine_gland_phen | 0.40425355 |
116 | MP0003953_abnormal_hormone_level | 0.39810635 |
117 | MP0004782_abnormal_surfactant_physiolog | 0.39594434 |
118 | MP0002092_abnormal_eye_morphology | 0.39288092 |
119 | MP0002697_abnormal_eye_size | 0.39081386 |
120 | MP0002837_dystrophic_cardiac_calcinosis | 0.38887285 |
121 | MP0005248_abnormal_Harderian_gland | 0.37983680 |
122 | MP0004883_abnormal_blood_vessel | 0.37810126 |
123 | MP0009672_abnormal_birth_weight | 0.37533223 |
124 | MP0008872_abnormal_physiological_respon | 0.36971554 |
125 | MP0005166_decreased_susceptibility_to | 0.35969888 |
126 | MP0005666_abnormal_adipose_tissue | 0.35214830 |
127 | MP0001243_abnormal_dermal_layer | 0.34488944 |
128 | MP0000249_abnormal_blood_vessel | 0.33636230 |
129 | MP0009384_cardiac_valve_regurgitation | 0.32997924 |
130 | MP0002168_other_aberrant_phenotype | 0.31817588 |
131 | MP0009115_abnormal_fat_cell | 0.31792197 |
132 | MP0000579_abnormal_nail_morphology | 0.31680098 |
133 | MP0002796_impaired_skin_barrier | 0.31243051 |
134 | MP0004381_abnormal_hair_follicle | 0.30951482 |
135 | MP0001853_heart_inflammation | 0.30764464 |
136 | MP0000230_abnormal_systemic_arterial | 0.30009887 |
137 | MP0005164_abnormal_response_to | 0.29995629 |
138 | MP0002970_abnormal_white_adipose | 0.29316945 |
139 | MP0006082_CNS_inflammation | 0.28459565 |
140 | MP0001845_abnormal_inflammatory_respons | 0.28343945 |
141 | MP0001881_abnormal_mammary_gland | 0.27129505 |
142 | MP0002060_abnormal_skin_morphology | 0.26110694 |
143 | MP0002090_abnormal_vision | 0.24678062 |
144 | MP0002132_abnormal_respiratory_system | 0.24466766 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.61351152 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.31035821 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.28494249 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.71520279 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.61593484 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.48463033 |
7 | Xanthomatosis (HP:0000991) | 6.33010482 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.52710882 |
9 | Complement deficiency (HP:0004431) | 5.37402229 |
10 | Joint hemorrhage (HP:0005261) | 4.96181355 |
11 | Hypolipoproteinemia (HP:0010981) | 4.92155110 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.67034792 |
13 | Hyperammonemia (HP:0001987) | 4.59635973 |
14 | Epidermoid cyst (HP:0200040) | 4.50177750 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.49469160 |
16 | Hyperglycinemia (HP:0002154) | 4.34930260 |
17 | Hypoalphalipoproteinemia (HP:0003233) | 4.32357537 |
18 | Abnormality of methionine metabolism (HP:0010901) | 4.27137117 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21311390 |
20 | Ketosis (HP:0001946) | 4.20746784 |
21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.13282841 |
22 | Fat malabsorption (HP:0002630) | 4.11619710 |
23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09195862 |
24 | Abnormality of complement system (HP:0005339) | 3.92436393 |
25 | Hypoglycemic coma (HP:0001325) | 3.86709082 |
26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.86644128 |
27 | Abnormality of glycine metabolism (HP:0010895) | 3.86369541 |
28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.86369541 |
29 | Hyperglycinuria (HP:0003108) | 3.84580630 |
30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80274412 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71938407 |
32 | Hypercholesterolemia (HP:0003124) | 3.68573349 |
33 | Hyperbilirubinemia (HP:0002904) | 3.44288564 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26364728 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24078181 |
36 | Spontaneous abortion (HP:0005268) | 3.22675175 |
37 | Hypochromic microcytic anemia (HP:0004840) | 3.16558825 |
38 | Purpura (HP:0000979) | 3.16077400 |
39 | Abnormality of carpal bone ossification (HP:0006257) | 3.09221668 |
40 | Hepatocellular carcinoma (HP:0001402) | 3.08516318 |
41 | Steatorrhea (HP:0002570) | 3.04089555 |
42 | Delayed CNS myelination (HP:0002188) | 3.03893701 |
43 | Abnormality of serum amino acid levels (HP:0003112) | 3.03125676 |
44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.99953646 |
45 | Small epiphyses (HP:0010585) | 2.99582523 |
46 | Abnormal tarsal ossification (HP:0008369) | 2.98832494 |
47 | Ketoacidosis (HP:0001993) | 2.95980205 |
48 | Myocardial infarction (HP:0001658) | 2.94916857 |
49 | Acanthocytosis (HP:0001927) | 2.93096273 |
50 | Skin nodule (HP:0200036) | 2.80586405 |
51 | Metabolic acidosis (HP:0001942) | 2.73801716 |
52 | Flat acetabular roof (HP:0003180) | 2.71146079 |
53 | Systemic lupus erythematosus (HP:0002725) | 2.69255810 |
54 | Broad alveolar ridges (HP:0000187) | 2.60366145 |
55 | Glomerulonephritis (HP:0000099) | 2.60175269 |
56 | Abnormality of purine metabolism (HP:0004352) | 2.59793262 |
57 | Vascular calcification (HP:0004934) | 2.57159588 |
58 | Abnormal gallbladder morphology (HP:0012437) | 2.56364231 |
59 | Lethargy (HP:0001254) | 2.55429932 |
60 | Osteomalacia (HP:0002749) | 2.50785890 |
61 | Cholelithiasis (HP:0001081) | 2.50779436 |
62 | Hypoglycemic seizures (HP:0002173) | 2.50533125 |
63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50467384 |
64 | Dicarboxylic aciduria (HP:0003215) | 2.50467384 |
65 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.46353080 |
66 | Spastic diplegia (HP:0001264) | 2.44460365 |
67 | Abnormal gallbladder physiology (HP:0012438) | 2.42686985 |
68 | Cholecystitis (HP:0001082) | 2.42686985 |
69 | Arthropathy (HP:0003040) | 2.42224882 |
70 | Cerebral edema (HP:0002181) | 2.40127939 |
71 | Amyloidosis (HP:0011034) | 2.40055145 |
72 | Mitral stenosis (HP:0001718) | 2.39703532 |
73 | Gout (HP:0001997) | 2.38548647 |
74 | Gingival bleeding (HP:0000225) | 2.36280753 |
75 | Poikilocytosis (HP:0004447) | 2.34747723 |
76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31760304 |
77 | Irritability (HP:0000737) | 2.31351524 |
78 | Cardiovascular calcification (HP:0011915) | 2.29792349 |
79 | Neonatal onset (HP:0003623) | 2.29133238 |
80 | Abnormal hand bone ossification (HP:0010660) | 2.28874866 |
81 | Esophageal varix (HP:0002040) | 2.27995563 |
82 | Broad palm (HP:0001169) | 2.27355628 |
83 | Abnormal ossification of hand bones (HP:0005921) | 2.27276254 |
84 | Increased serum pyruvate (HP:0003542) | 2.25687619 |
85 | Menorrhagia (HP:0000132) | 2.24661740 |
86 | Potter facies (HP:0002009) | 2.21003060 |
87 | Facial shape deformation (HP:0011334) | 2.21003060 |
88 | Thrombophlebitis (HP:0004418) | 2.19331682 |
89 | Malnutrition (HP:0004395) | 2.17620438 |
90 | Abnormality of the lumbar spine (HP:0100712) | 2.16606168 |
91 | Pancreatitis (HP:0001733) | 2.13558926 |
92 | Epiphyseal dysplasia (HP:0002656) | 2.13304004 |
93 | Asymmetry of the thorax (HP:0001555) | 2.13048282 |
94 | Hepatoblastoma (HP:0002884) | 2.12807372 |
95 | Enlarged kidneys (HP:0000105) | 2.12247542 |
96 | Sensorimotor neuropathy (HP:0007141) | 2.09158523 |
97 | Abnormality of glycolysis (HP:0004366) | 2.06827635 |
98 | Abnormality of the nasal septum (HP:0000419) | 2.06549182 |
99 | Abnormality of the gallbladder (HP:0005264) | 2.05540376 |
100 | Late onset (HP:0003584) | 2.04490699 |
101 | Brushfield spots (HP:0001088) | 2.04004898 |
102 | Vomiting (HP:0002013) | 2.03040214 |
103 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02125189 |
104 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.01880524 |
105 | Hemorrhage of the eye (HP:0011885) | 2.01479371 |
106 | Vaginal fistula (HP:0004320) | 1.99236451 |
107 | Generalized aminoaciduria (HP:0002909) | 1.96435329 |
108 | Abnormality of the Achilles tendon (HP:0005109) | 1.96054535 |
109 | Opisthotonus (HP:0002179) | 1.95763445 |
110 | Abnormality of iron homeostasis (HP:0011031) | 1.94677540 |
111 | Rickets (HP:0002748) | 1.93071051 |
112 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92423416 |
113 | Abnormal foot bone ossification (HP:0010675) | 1.92148723 |
114 | Abnormal cartilage morphology (HP:0002763) | 1.88429509 |
115 | Diastasis recti (HP:0001540) | 1.86874239 |
116 | Nephritis (HP:0000123) | 1.84540607 |
117 | Alacrima (HP:0000522) | 1.84405987 |
118 | Bifid scrotum (HP:0000048) | 1.84264077 |
119 | Reticulocytosis (HP:0001923) | 1.84258055 |
120 | Hypophosphatemic rickets (HP:0004912) | 1.83792284 |
121 | Hydroxyprolinuria (HP:0003080) | 1.81205973 |
122 | Abnormality of proline metabolism (HP:0010907) | 1.81205973 |
123 | Renal cortical cysts (HP:0000803) | 1.79939551 |
124 | Elevated hepatic transaminases (HP:0002910) | 1.79793664 |
125 | Alkalosis (HP:0001948) | 1.79181042 |
126 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78454371 |
127 | Abnormality of the wing of the ilium (HP:0011867) | 1.76511667 |
128 | Flared iliac wings (HP:0002869) | 1.74761070 |
129 | Status epilepticus (HP:0002133) | 1.74240956 |
130 | Abnormal delivery (HP:0001787) | 1.72986489 |
131 | Pulmonary embolism (HP:0002204) | 1.72414177 |
132 | Epistaxis (HP:0000421) | 1.71715228 |
133 | Peritonitis (HP:0002586) | 1.66910150 |
134 | Irregular epiphyses (HP:0010582) | 1.65870284 |
135 | Absent epiphyses (HP:0010577) | 1.65257222 |
136 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.65257222 |
137 | Abnormality of the acetabulum (HP:0003170) | 1.64827115 |
138 | Cupped ribs (HP:0000887) | 1.64560504 |
139 | Widely patent fontanelles and sutures (HP:0004492) | 1.64352267 |
140 | Submucous cleft hard palate (HP:0000176) | 1.63516088 |
141 | Neonatal death (HP:0003811) | 1.61686893 |
142 | Joint swelling (HP:0001386) | 1.61627373 |
143 | Abnormality of pain sensation (HP:0010832) | 1.60721624 |
144 | Impaired pain sensation (HP:0007328) | 1.60721624 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.13562969 |
2 | SIK1 | 4.58833790 |
3 | FGFR4 | 4.57568948 |
4 | ERN1 | 4.24100035 |
5 | WNK4 | 3.23318520 |
6 | CDK12 | 3.19096914 |
7 | INSRR | 3.09664547 |
8 | TAOK3 | 3.08058615 |
9 | ERBB4 | 2.84138837 |
10 | TYRO3 | 2.55007562 |
11 | PKN2 | 2.42554676 |
12 | FGFR1 | 2.30578375 |
13 | MAP2K4 | 2.30161031 |
14 | MST1R | 2.21584922 |
15 | FLT3 | 2.04211969 |
16 | MAPK11 | 1.95629348 |
17 | TRIB3 | 1.92808720 |
18 | AKT3 | 1.88408543 |
19 | PIK3CG | 1.88148631 |
20 | TYK2 | 1.74022295 |
21 | LATS1 | 1.73335335 |
22 | WNK1 | 1.61525989 |
23 | DAPK2 | 1.59268364 |
24 | EIF2AK1 | 1.52771575 |
25 | PTK6 | 1.50764019 |
26 | SIK2 | 1.49940512 |
27 | NEK9 | 1.49828285 |
28 | ABL2 | 1.48010537 |
29 | FRK | 1.45654278 |
30 | EEF2K | 1.43313043 |
31 | FGFR2 | 1.37158196 |
32 | KDR | 1.33711093 |
33 | MAP3K2 | 1.28903860 |
34 | JAK2 | 1.26012107 |
35 | PRKAA2 | 1.14373635 |
36 | MAP3K7 | 1.14289172 |
37 | DDR2 | 1.08847452 |
38 | GRK6 | 1.08001115 |
39 | ERBB2 | 1.06705844 |
40 | MAP2K3 | 1.05668438 |
41 | MAP3K10 | 1.05080271 |
42 | JAK1 | 1.04154977 |
43 | PINK1 | 1.03356781 |
44 | TBK1 | 0.98899857 |
45 | MAPK4 | 0.96593732 |
46 | MET | 0.96414584 |
47 | CDK7 | 0.94088239 |
48 | PRKCZ | 0.89482914 |
49 | MAPKAPK3 | 0.88591173 |
50 | MAP3K14 | 0.86249560 |
51 | MAP3K3 | 0.84914817 |
52 | EPHB1 | 0.84188873 |
53 | CDK6 | 0.83741807 |
54 | BRSK2 | 0.82625871 |
55 | FGR | 0.81570270 |
56 | MAPK12 | 0.81414356 |
57 | EPHA2 | 0.80943727 |
58 | EPHA3 | 0.80220972 |
59 | PRKACG | 0.78729996 |
60 | MAP3K11 | 0.77910556 |
61 | BRSK1 | 0.76891888 |
62 | RPS6KB1 | 0.76421453 |
63 | STK38L | 0.75448697 |
64 | CAMK1D | 0.75041427 |
65 | TIE1 | 0.74868943 |
66 | NEK1 | 0.74036114 |
67 | NTRK3 | 0.73668434 |
68 | SGK1 | 0.72895478 |
69 | SMG1 | 0.72049018 |
70 | MAPK15 | 0.71336594 |
71 | DYRK1B | 0.70654840 |
72 | STK39 | 0.68761321 |
73 | KSR2 | 0.68594095 |
74 | CSK | 0.67839440 |
75 | GSK3A | 0.67364204 |
76 | NEK2 | 0.67328720 |
77 | RIPK1 | 0.66821369 |
78 | CAMK2G | 0.66697848 |
79 | PRKAA1 | 0.66037634 |
80 | TGFBR2 | 0.65518432 |
81 | BCR | 0.63926688 |
82 | CDC42BPA | 0.61103336 |
83 | PTK2 | 0.59954454 |
84 | SGK3 | 0.59926629 |
85 | MAP2K6 | 0.59307735 |
86 | BRD4 | 0.59041365 |
87 | FGFR3 | 0.57822783 |
88 | CSF1R | 0.55698941 |
89 | * CSNK1E | 0.55212433 |
90 | MAPK7 | 0.55059263 |
91 | PDPK1 | 0.50343831 |
92 | IKBKE | 0.49242466 |
93 | PRKCQ | 0.49148884 |
94 | IRAK3 | 0.48269175 |
95 | MAP2K1 | 0.46759218 |
96 | CSNK1D | 0.46714303 |
97 | RET | 0.46573720 |
98 | TAOK2 | 0.46319461 |
99 | IGF1R | 0.45029210 |
100 | CSNK1G1 | 0.44557162 |
101 | MAP3K5 | 0.43902835 |
102 | GRK1 | 0.43840996 |
103 | CDK4 | 0.43830178 |
104 | CDK8 | 0.42588029 |
105 | PBK | 0.42201597 |
106 | SGK2 | 0.42092009 |
107 | PRKCG | 0.40527773 |
108 | SRC | 0.40339119 |
109 | CSNK2A2 | 0.39076094 |
110 | MTOR | 0.38996469 |
111 | EPHA4 | 0.38919674 |
112 | NTRK2 | 0.35468739 |
113 | RPS6KA3 | 0.35060725 |
114 | MAP3K6 | 0.34853438 |
115 | MATK | 0.34689559 |
116 | CSNK2A1 | 0.34297126 |
117 | EGFR | 0.33925180 |
118 | PKN1 | 0.33749639 |
119 | ICK | 0.33696951 |
120 | SCYL2 | 0.32692168 |
121 | PDK1 | 0.32404381 |
122 | MAP3K13 | 0.32082459 |
123 | PRKG1 | 0.29671276 |
124 | SGK494 | 0.29601531 |
125 | SGK223 | 0.29601531 |
126 | PDGFRB | 0.29572320 |
127 | YES1 | 0.29348684 |
128 | CAMK4 | 0.29206143 |
129 | CDK9 | 0.28526538 |
130 | MAP3K1 | 0.26671590 |
131 | MELK | 0.26092585 |
132 | PRKCA | 0.25853522 |
133 | PDGFRA | 0.24190601 |
134 | NLK | 0.24053093 |
135 | CSNK1G2 | 0.23806295 |
136 | LATS2 | 0.23472996 |
137 | BMX | 0.23413213 |
138 | CAMK1G | 0.23185630 |
139 | PAK3 | 0.22956056 |
140 | MAP2K2 | 0.22495768 |
141 | PIK3CA | 0.21332228 |
142 | STK3 | 0.20744383 |
143 | ABL1 | 0.20371635 |
144 | MAPK3 | 0.19213186 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44910277 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.86862881 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44100951 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32773479 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.11396392 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.87045720 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67224588 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64267628 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63272244 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56744756 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48680390 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36793435 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20808788 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13072594 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09421466 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.02351835 |
17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92340014 |
18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91445593 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88588018 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88027989 |
21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87812388 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85085070 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82773107 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81095091 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76994848 |
26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72150372 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69815873 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65634439 |
29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65250977 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62736155 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62020315 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59701955 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55920587 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51144152 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48921121 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.47762221 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42522757 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35070071 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33070466 |
40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32573937 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31584507 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27127977 |
43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23454991 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22299246 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.21592545 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21514305 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16947560 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13681916 |
49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05589235 |
50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02534895 |
51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02049725 |
52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99987423 |
53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99514943 |
54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98196815 |
55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96600681 |
56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92512156 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89562009 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86846571 |
59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84775062 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 0.81263892 |
61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79231440 |
62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70558833 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67309032 |
64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63892224 |
65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59022820 |
66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57527968 |
67 | Pertussis_Homo sapiens_hsa05133 | 0.55655962 |
68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55211936 |
69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46980482 |
70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45195979 |
71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35509399 |
72 | Prion diseases_Homo sapiens_hsa05020 | 0.33467858 |
73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25818648 |
74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24951094 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.23418320 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22532744 |
77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22514424 |
78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20792396 |
79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20786011 |
80 | Mineral absorption_Homo sapiens_hsa04978 | 0.15177084 |
81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.14580174 |
82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14576945 |
83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09727460 |
84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08201604 |
85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02223369 |
86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2426832 |
87 | Amoebiasis_Homo sapiens_hsa05146 | -0.2383396 |
88 | Bladder cancer_Homo sapiens_hsa05219 | -0.2372154 |
89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2323786 |
90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2217112 |
91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1946743 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1813240 |
93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1764970 |
94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1736073 |
95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1675295 |
96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1668964 |
97 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1652839 |
98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1607020 |
99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1537364 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1409899 |
101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1006988 |
102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0980196 |
103 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0890280 |
104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0792022 |
105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0749167 |
106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0733643 |
107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.0693975 |
108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0578183 |
109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0574437 |
110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0564894 |
111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.0311060 |